§35.2063. Records of dosages of unsealed byproduct material for medical use.
10 C.F.R. § 35.2063
A licensee shall maintain a record of dosage determinations required by § 35.63 for 3 years.
The record must contain—
The radiopharmaceutical;
The patient's or human research subject's name, or identification number if one has been assigned;
The prescribed dosage, the determined dosage, or a notation that the total activity is less than 1.1 MBq (30 µCi);
The date and time of the dosage determination; and
The name of the individual who determined the dosage.
Notes, amendments, and revision history
Authority
Authority: Atomic Energy Act of 1954, secs. 81, 161, 181, 182, 183, 223, 234, 274 (42 U.S.C. 2111, 2201, 2231, 2232, 2233, 2273, 2282, 2021); Energy Reorganization Act of 1974, secs. 201, 206 (42 U.S.C. 5841, 5846); 44 U.S.C. 3504 note.
Source
Source: 67 FR 20370, Apr. 24, 2002, unless otherwise noted.